Bacil Pharma closes trading window for designated persons ahead of financial results
Bacil Pharma Limited informed the BSE Limited that the trading window for designated persons will be closed from October 1, 2026, until 48 hours after the conclusion of the Board of Directors meeting to consider the unaudited financial results for the quarter and half year ended September 30, 2026, with the date of the board meeting to be intimated separately.